Long non‐coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR‐133a to regulate IGF‐1R expression
Male
0303 health sciences
Carcinoma, Hepatocellular
Epithelial-Mesenchymal Transition
Tumor Suppressor Proteins
Liver Neoplasms
Original Articles
Middle Aged
Receptor, IGF Type 1
3. Good health
Gene Expression Regulation, Neoplastic
MicroRNAs
03 medical and health sciences
Cell Movement
Cell Line, Tumor
Humans
Female
RNA, Long Noncoding
Cell Proliferation
Signal Transduction
DOI:
10.1111/jcmm.14384
Publication Date:
2019-06-17T16:53:07Z
AUTHORS (4)
ABSTRACT
Abstract Long non‐coding RNA (lncRNA) deleted in lymphocytic leukaemia 1 (DLEU1) was reported to be involved the occurrence and development of multiple cancers. However, exact expression, biological function underlying mechanism DLEU1 hepatocellular carcinoma (HCC) remain unclear. In this study, real‐time quantitative polymerase chain reaction (qRT‐PCR) HCC tissues cell lines revealed that expression up‐regulated, increased closely associated with advanced tumour‐node‐metastasis stage, vascular metastasis poor overall survival. Function experiments showed knockdown significantly inhibited proliferation, colony formation, migration invasion, suppressed epithelial mesenchymal transition (EMT) process via increasing E‐cadherin decreasing N‐cadherin Vimentin. Luciferase reporter gene assay immunoprecipitation (RIP) demonstrated could sponge miR‐133a. Moreover, miR‐133a inhibition reversed suppression effects on cells. Besides, we found silenced decreased insulin‐like growth factor receptor (IGF‐1R) (a target miR‐133a) its downstream signal PI3K/AKT pathway cells, while inhibitor partially trend. Furthermore, impaired tumour vivo by regulating miR‐133a/IGF‐1R axis. Collectively, these findings indicate promoted progression sponging regulate IGF‐1R expression. Deleted 1/miR‐133a/IGF‐1R axis may a novel for treatment HCC.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....